EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients—Narrative Review

Mariusz Kęska, Milena Kęska, Mirosław Perliński iD, Piotr Pabich, Dariusz Onichimowski

Nutrients · 17.03.2026 · 18 (6) · 939

DOI: 10.3390/nu18060939 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 17.03.2026. Verfasst von Mariusz Kęska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-727 Olsztyn, P…. Hauptthemen laut MEDLINE: Critical Illness, Fish Oils, Fat Emulsions, Intravenous, Parenteral Nutrition. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Injectable lipid emulsions are an integral component of parenteral nutrition, providing energy as well as essential fatty acids. However, conventional soybean oil–based emulsions, which are rich in omega-6 fatty acids, are associated with a risk of exacerbating pro-inflammatory responses and immunosuppression, which is of particular importance in critically ill patients. The aim of this review is to present the significance of the composition of modern injectable lipid emulsions, with particular emphasis on emulsions containing fish oil as a source of omega-3 fatty acids (EPA and DHA), and to discuss their potential clinical benefits in selected critical conditions.

Methods

This narrative review discusses the rationale for modern mixed-oil ILE, with a focus on fish oil as a source of EPA and DHA, and summarizes potential clinical benefits in selected critical care settings.

Results

Modern injectable lipid emulsions combine long-chain triglycerides derived from soybean oil (omega-6), MCTs, olive oil (omega-9), and fish oil (omega-3). Adjusting the supply of individual fractions affects cell membrane structure, signaling pathways, gene expression, and the profile of lipid mediators produced, including specialized pro-resolving mediators (SPMs). ESPEN guidelines and international recommendations emphasize the need to use lipids in parenteral nutrition, preferring mixed-oil ILE supplemented with fish oil. The cited meta-analyses and clinical studies indicate that omega-3-containing emulsions may reduce the risk of infections and sepsis; shorten hospital stay, ICU length of stay, and duration of mechanical ventilation in patients with sepsis; as well as improve outcomes in acute pancreatitis; lower the risk of delirium; and reduce the incidence of delayed gastric emptying.

Conclusions

Available data support the use of mixed-oil ILE supplemented with fish oil in the parenteral nutrition of critically ill patients as a strategy with immunomodulatory and pro-resolving potential that may translate into improved clinical outcomes. However, further well-designed randomized trials are needed to optimize dosing and administration regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessFish OilsFat Emulsions, IntravenousParenteral NutritionImmunomodulationHumansTreatment OutcomeFatty Acids, Omega-3Immunonutrition Diet

Stichwörter der Autor:innen

ICU nutritionfish oillipid emulsionparenteral nutrition

Substanzen

Fish OilsFat Emulsions, IntravenousFatty Acids, Omega-3

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Care, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-727 Olsztyn, Poland.
  • Clinical Department of Anaesthesiology and Intensive Care, Regional Specialist Hospital in Olsztyn, 10-045 Olsztyn, Poland.
  • Fresenius Kabi Poland, Aleje Jerozolimskie 134, 02-305 Warsaw, Poland.
  • Hospital Pharmacy, Regional Specialist Hospital in Olsztyn, 10-045 Olsztyn, Poland.

ORCID-Profile: Mirosław Perliński

Zitieren

APA

Kęska, M., Kęska, M., Perliński, M., Pabich, P., & Onichimowski, D. (2026). Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients—Narrative Review. Nutrients, 18(6), 939. https://doi.org/10.3390/nu18060939

Vancouver

Kęska M, Kęska M, Perliński M, Pabich P, Onichimowski D. Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients—Narrative Review. Nutrients. 2026;18(6):939. doi:10.3390/nu18060939

BibTeX
@article{Kska2026,
  author = {Kęska, Mariusz and Kęska, Milena and Perliński, Mirosław and Pabich, Piotr and Onichimowski, Dariusz},
  title = {Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients—Narrative Review},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {939},
  doi = {10.3390/nu18060939}
}
Kostenlos starten →